Baroda BNP Paribas Health and Wellness Fund
Pharma and Healthcare · Direct plan · Growth
₹11.33
+₹0.09 (+0.82%) today
NAV on 20 Nov 2026 · Near its 52-week high
Returns
Up to a year
| Period | This fund | BSE Healthcare | Rank |
|---|---|---|---|
| 1 month | +10.26% | +11.49% | 14/19 |
| 3 months | +3.83% | +5.00% | 9/18 |
| 6 months | +11.02% | +11.71% | 15/18 |
| This year | +18.67% | +21.57% | 15/18 |
| 1 year | +16.91% | +19.35% | 14/17 |
Longer term
| This fund | BSE Healthcare | BSE Healthcare | Category | ||||
|---|---|---|---|---|---|---|---|
| Total | A year | Total | A year | A year | Rank | ||
| 2 years | – | – | +12.1% | – | |||
| 3 years | – | – | +21.6% | – | |||
| 5 years | – | – | +15.9% | – | |||
| 7 years | – | – | +22.0% | – | |||
| 10 years | – | – | +13.4% | – | |||
| Since inception | +13.32% | +9.4% | +14.6% | – | |||
₹1 lakh invested at the start (Jun 2025) is ₹1.13 lakh today.
From the plan's own NAV, to 20 Nov 2026. Rank 1 is best. Past returns are no guide to the future.
RiskWorst fall -11.1% · volatility 13.3% a year
Volatility, since launch
13.3%
BSE Healthcare 16.1%
Worst fall
-11.1%
Jan 2026, back by May 2026
Up months
65%
last 3 years
Against other pharma and healthcare funds, last 3 years (worst fall: 5 years)
Yearly cost
! 1.47%
Dearer than peers · average 1.10%
17 of 18
More measures ›Fewer measures ‹
Sharpe ratio, 3 years
N/A
Return above the CRISIL Overnight Index per unit of volatility
Sortino ratio, 3 years
N/A
The same, counting only falls
Alpha vs BSE Healthcare
N/A
Yearly return beyond what its beta explains
Beta vs BSE Healthcare
N/A
Moves this much when the index moves 1%
Share of the index's rises
84%
In months the index rose
Share of the index's falls
99%
In months the index fell; lower is better
Over the last 3 years, from the fund's NAVs against the BSE Healthcare.
Where it ranksAgainst 19 pharma and healthcare funds
Where it ranks
among 19 pharma and healthcare funds, Direct plans1 year
14 of 17
Bottom quarter
Lowest cost
17 of 18
Bottom quarter
| Best over 3 years | 3 years | A year | Cost | Size |
|---|---|---|---|---|
| 1HDFC Pharma and Healthcare Fund | +123.0% | +30.6% | 1.04% | ₹3,666 Cr |
| 2SBI Healthcare Opportunities Fund | +94.4% | +24.8% | 1.00% | ₹6,067 Cr |
| 3Mirae Asset Healthcare Fund | +90.9% | +24.0% | 0.61% | ₹3,562 Cr |
| 4UTI Healthcare Fund | +87.3% | +23.3% | 1.34% | ₹1,433 Cr |
| 5LIC MF Healthcare Fund | +80.9% | +21.9% | 1.38% | ₹96.54 Cr |
| 17Baroda BNP Paribas Health and Wellness Fund this fund | – | – | 1.47% | ₹477 Cr |
Every fund in the category computed from its own NAV the same way, to 20 Nov 2026. All Pharma and Healthcare funds ›
What stands out
What it holds
35 holdings · as of Aug 2026
- 1Sun Pharmaceutical Industries Ltd9.01%
- 2Divi'S Laboratories Ltd8.01%
- 3Torrent Pharmaceuticals Ltd7.99%
- 4Ipca Laboratories Ltd6.23%
- 5Lupin Ltd5.99%
- 6Laurus Labs Ltd5.66%
- 7Apollo Hospitals Enterprises Ltd5.44%
- 8Fortis Healthcare Ltd4.50%
- 9Astrazeneca Pharma India Ltd3.56%
- 10Glenmark Pharmaceuticals Ltd3.42%
SIP returns of pharma and healthcare funds · All pharma and healthcare funds · Fund screener
About Baroda BNP Paribas Health and Wellness Fund Direct Growth
Baroda BNP Paribas Health and Wellness Fund Direct Growth is a Sector Specific - Pharma equity fund from Baroda BNP Paribas Asset Management India Pvt. Ltd., launched on 23 Jun 2025. Its benchmark is the BSE Healthcare Index. The expense ratio is 1.47% a year. It manages ₹477 crore. The NAV was ₹11.33 on 20 Nov 2026.
Questions about Baroda BNP Paribas Health and Wellness Fund
What is the NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
The NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth was ₹11.33 on 20 Nov 2026. Mutual fund NAVs are published once a day, after markets close.
What are the returns of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
Baroda BNP Paribas Health and Wellness Fund Direct Growth returned 16.9% over 1 year, to 20 Nov 2026, worked out from its own daily NAV. It returned more than the BSE Healthcare Index in 0 of 2 calendar years since 2025.
What is the expense ratio of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
1.47% a year. It is taken from the fund's assets every day, so the NAV and every return shown are already after this cost.
Can NRIs in the UAE invest in Baroda BNP Paribas Health and Wellness Fund?
NRIs can generally invest once KYC is complete, paying from an NRE or NRO account. Baroda BNP Paribas Mutual Fund accepts investors living in the US or Canada only on conditions, per its own documents checked on 15 Nov 2026. Rules change, so confirm with the fund house.
How are Baroda BNP Paribas Health and Wellness Fund gains taxed for NRIs?
India taxes gains on equity funds at 20% on units held 12 months or less, and at 12.5% on gains above ₹1.25 lakh a year on units held longer, plus cess and any surcharge. For NRIs the tax is deducted when units are redeemed. The UAE has no personal income tax, and the India UAE tax treaty may apply, so confirm your position with a tax adviser.
Rolling returns shows every period, not just the latest.
Compare every pharma and healthcare fund on returns, volatility, worst fall and cost.

















